Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Express Scripts
Harvard Business School
McKinsey
Fuji
US Army
Moodys
Chinese Patent Office

Generated: June 21, 2018

DrugPatentWatch Database Preview

CHYMEX Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Chymex patents expire, and when can generic versions of Chymex launch?

Chymex is a drug marketed by Savage Labs and is included in one NDA.

The generic ingredient in CHYMEX is bentiromide. There are three drug master file entries for this compound. Additional details are available on the bentiromide profile page.
Summary for CHYMEX
Drug patent expirations by year for CHYMEX
Synonyms for CHYMEX
(S)-4-((2-(benzoylamino)-3-(4-hydroxyphenyl) -1-oxopropyl)amino)benzoic acid
(S)-4-((2-(Benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)benzoic acid
(S)-p-(|A-benzamido-p-hydroxyhydrocinnamamido) benzoic acid
(S)-p-(alpha-Benzamido-p-hydroxyhydrocinnamamido)benzoic acid
106B971
2260AH
239IF5W61J
37106-97-1
4-(N-benzoyl-L-tyrosylamino)benzoic acid
4-[(2S)-3-(4-hydroxyphenyl)-2-(phenylformamido)propanamido]benzoic acid
4-[(N-benzoyl-L-tyrosyl)amino]benzoic acid
AB01566933_01
ACM37106971
bentiromide
Bentiromide [USAN:INN:BAN:JAN]
Bentiromido
Bentiromido [INN-Spanish]
Bentiromidum
Bentiromidum [INN-Latin]
Benzoyltyrosyl-p-aminobenzoic acid
Benzoyltyrosyl-p-aminobenzoic acid (Btpaba)
BRN 2910938
BT-PABA
Btpaba
Btpaba Pft
BTPABA, PFT
BZ-TYR-4-ABZ-OH
C12779
CHEBI:31263
CHEMBANK2959
CHEMBL1200368
D01346
D0L0SW
DB00522
DTXSID2048377
E 2663
E-2663
EINECS 253-349-8
K-8226
MFCD00055768
N-benzoyl-L-tyrosyl-p-aminobenzoate
N-Benzoyl-L-tyrosyl-p-aminobenzoic acid
p-((N-Benzoyl-L-tyrosin)amido)benzoic acid
PFT
Ro 11-7891
SCHEMBL151634
SR-01000883958
SR-01000883958-1
UNII-239IF5W61J
ZINC608204

US Patents and Regulatory Information for CHYMEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs CHYMEX bentiromide SOLUTION;ORAL 018366-001 Dec 29, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
US Department of Justice
Citi
Chinese Patent Office
McKesson
Farmers Insurance
Cantor Fitzgerald
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.